• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Derivatives of 9-chloroprednisolone of the formula <IMAGE> in which R1 is alkanoyl with 1 to 8 carbon atoms or benzoyl, and X is fluorine, chlorine, hydroxyl, alkanoyloxy with 1 to 8 carbon atoms or benzoyloxy, are prepared. These compounds are obtained by adding HOCl onto the corresponding DELTA <9,11>-prednisolones. The compounds can be used for the treatment of inflammations.
    公开号:SU751327A3
    申请号:SU782672298
    申请日:1978-10-13
    公开日:1980-07-23
    发明作者:Аннен Клаус；Лаурент Хенри；Хофмайстер Хельмут；Вихерт Рудольф；Вендт Ханс；Фридрих Капп Иоахим
    申请人:Шеринг Аг (Фирма)；
    IPC主号:
    专利说明:

    1 I A method is proposed for the preparation of new derivatives of 9-chloroprednisolone of the general formula where R. is an alkane-carbon group with 1-4 carbon atoms or a benzene group; X is a fluorine atom, a chlorine atom, a hydroxyl group with valuable pharmacological properties. The use of the method of orthoesters hydrolysically known by steroid chemistry or by using trimethylsilyl halide or triphenylmethyl halide l makes it possible to obtain new derivatives of 9-chloro prednisolone of the general formula 1. The purpose of the invention is to obtain new 9-chloroprednisolone derivatives with pharmacological activity. The goal is achieved by describing the first method such that the ortho ester of the general formula SCO OR2 0 / (2) where R2 is an alkyl group, I is a hydrogen atom, the C | -CY alkyl group or the phenyl group is split hydrolytically or with trimethylsilyl halide or triphenylmethyl halide, after which the obtained target products are isolated by known methods. The pharmacological properties of the compounds were verified by the following experiments. A. Anti-inflammatory properties when applied topically in rat ears. The substance to be tested is dissolved in an irritant medium consisting of 4 1. pyridine, 1 part distilled water, 5 parts ether and 10 parts 4% aqueous solution of croton oil in ether.
    Strips of felt are impregnated with this experimental solution, which are held by tweezers and then, with gentle pressure, kept for 15 seconds on the right ear of a male rat weighing 100-160 g. The left ear serves as a control and is not subjected to processing. Three hours after the application of the animals, the circles of 9 mm diameter were cut out from the ears. The difference in mass between the right and left ear circles is an indication of the resulting edema. The dose of the tested substance is determined; tva, at which after 3 hours of observing.% 50% inhibition of edema is observed:
    B. Anti-inflammatory properties when applied to the paw in a rat's paw. SPF rats weighing 130-150 g were injected into the right hind paw with 0.1 ml of a 5% solution of a Mycobacterine butyricum suspension (obtained from an American company Difko) in order to create a flashback center. Before injection, rat paw volume is measured. 24 hours after the injection, the paw volume for measuring the stack size is measured again. Then, rats are injected Subcutaneously with different amounts of the tested substances dissolved in a mixture of 20% benzyl benzoate and 71% cas; .orovo.go oil. After the next 2-4 hours, paw volume is measured again.
    The control animals undergo a similar treatment, but they inject a mixture of benzyl benzoate with castor oil without a test substance. From the obtained paw volumes, the amount of the test substance is determined in the usual way, which is necessary for 50% healing of paw edema.
    B, Thymolytic action after oral administration. In SPF rats weighing 70-110 g, the work of the adrenaline device is disrupted by anesthesia. 6 animals in each case form an experimental group, which after 3 days, the test substance is orally administered. On the fourth day, the animals are sacrificed and the mass of the thymus is determined. Control animals are treated in the same way, but only a mixture of benzyl benzoate and castor oil is obtained without a test substance. From the obtained data on the mass of thymus in the usual way, the quantities of the substance to be tested are determined at which 50% thymolysis is observed.
    For comparison, the structural analogue of 9-chloroprednisolium and its 21-acetate, as well as beclomethasone-17,21-dipropionate (9o4-chloro-11 | L-hydroxy-1 b | L-methyl-17 (L, 21- dipropionyloxy-1,4-pregnadien-3, 20-dione).
    The data obtained in these experiments are given in the table.
    9o (.- chloro-111L, 17ob, 21-trihidr6ksi-1,4-pregnadien-3, 20 - DION
    21-acetoxy-9 (X.-chloro-11/5 D7Dt-dihydroxy-l, 4-predgnadien-3, 20-dione
    9sb-chloro-11 (b-hydroxy-1br-methyl-17o6, 21-dipropionyloxy-1,4-pregnadieH 3,
    17cb-acetoxy-9oC-chloro-11p |, 21-hydroxy -1,4-pregnadien-3, 20-dione
    96-chloro-11 | b, 21-dihydroxy-17ob-pro pionyloxy-1,4-pregnadien-3, 20-dione.
    21-acetoxy-9ob-chloro 11 | 5-hydroxy-176-propionyloxy-1, 4-pregnadien-3, 20dione
    21-acetoxy-17 | zb-benzoyloxy-9 L-chloro-11r-hydroxy-1, 4-pregnadien 3,20-dione
    17th-benzoyl-9os chloro-11) 5-hydroxy-21-propionyloxy-1, 4-pregnadien-3, 20-dione
    6.3
    0.4
    6.0 0.6
    thirty
    2.0 30 9.5 30 4.8
    25
    4.8
    thirty
    thirty
    Similar results are obtained — if the pharmacological effects of 9-chloroprednisolone derivatives are determined by vasoconstriction experiments and experiments with sodium and potassium in the body.
    These new compounds are suitable in combination with carriers used in pharmacology for the local treatment of control dermatitis, eczema of various kinds, neurodermatosis, erythroderma, burns.
    Example 1. / X. 5.0 g of 9A-chloro-11 / i, 17a ,, 21-trihydroxy-1, 4-pregnain-3, 20-dione is mixed with 500 ml of benzene, 40 ml of dimethylformamide and 500 ml of absolute pyridinosylate. The resulting mixture is heated, distilled at a bath temperature of 130 ° C, 50 ml of the solution, is added to the distillation with 60 ml of o-triethyl ether ether and the remaining benzene is again distilled for 2.5 hours. The residue is mixed with 2.4 ml of pyridine, concentrated under vacuum, and 1706, 21- (1-ethoxybenzylidenedioxy) -9l-chloro-11 / L-hydroxy-1, 4-pregnadien-3, 20-dione are obtained as an oily product. .
    B. The resulting crude product is mixed with 150 G4L of methanol, 54 ml of 0.1 n aqueous acetic acid and b ml of 0.1 n. an aqueous solution of sodium acetate and heated for 90 minutes with a backflow. After that, the reaction mixture is concentrated under vacuum, the residue is mixed with water and extracted with ethyl acetate. The organic phase is washed with water, concentrated under vacuum, the residue is purified on a chromatographic column with silica gel, recrystallized from a mixture of acetone and hexane, and then receive, 7 g 17s1y-benzoyloxy-9l-chloro-IL, 21-dihydroxy-1, 4-pregnadiene -3, 20-dione, so pl. 216 ° C (decomposition).
    Example 2. 0.5 g 17 (U.-benzoyloxy-9o.; - chlorine-11 (5.21-dihydroxy-1, 4-pregnadien-3, 20-dione is stirred with 10 ml of formic acid at room temperature for 24 h. Then the reaction mixture is poured into ice water, extracted with dichloromethane, the organic phase is washed, dried over sodium sulfate, concentrated in vacuo and 400 mg of 17-6-benzoyloxy-9-6-chloro-21-formyloxy-11 | L-hydroxy are obtained. -1, 4-pregnadien-3, 20-dione in the form of a frozen glassy mass, oi + 58 ° (Chloroform).
    Example 3.1.5g 17l-benzoyloxy-9l-chloro-11, d, 21-dihydroxy-1, 4-pregnadien-3, 20-dione is mixed with 17 ml of pyridine and 8.0 ml of acetic anhydride and stirred for 1 h.
    at 0 ° C. The reaction mixture is then poured into ice-cold water, the product that is separated out is filtered off, dissolved in dichloromethane, the organic phase is passed through, dried over sodium sulfate and concentrated under vacuum. The residue is passed through a chromatographic column with silica gel along with methylene chloride with acetone, recrystallized from acetic acid and hexane, after which 1.2 g of 21-acetoxy-17o are obtained (- benzoyloxy-9l-chloro-11 | 3-hydroxy-1, 4 -pregnadiene-3,20-dione, mp 221s (decomposition).
    Example 4. 1.5 g of 17sL-benzo5-iloxy-Eob-chlor-Ir, 21-dihydroxy-1, 4-pregnadien-3,20-dione is mixed with 17 ml of pyridine and 8.0 ml of propionic anhydride and for 1 h stirred at 0 ° C. Process
    0 the reaction mixture, as in example 3, and get 960 mg of 17 ° C-benzoyloxy-9c-chlor-11/5-hydroxy-21-propionyloxy-1, 4-pregnadien-3, 20-dione, so pl. 226 ° C (decomposition),
    5 Example 5. 2.3 g of 17cc-benzoyloxy-9a:, -chloro-11/5, 21-dihydroxy-1, 4-pregnadien-3, 20-dione are mixed with 50 ml of pyridine and 25 ml of butyric anhydride and stirred
    0 for 16 hours at room temperature. The reaction mixture is treated according to the procedure described in Example 3 and 2.0 g of 17 | X.-benzoyloxy-21-butyryloxy-9og.-Chloro-Ir-hydroxy-1,4-pregnadien-3,20-dione are obtained, m.p. 226 ° C (decomposition).
    Example 6. 2.3 g of 17c-benzoyloxy-9 | X-chloro-11p, 21-dihydroxy-1, 4-pregnadiene-3, 20-dione are mixed with 50 ml of pyridine and 25 ml of anhydride
    0 valeric acid and stirred for 16 h at room temperature. The reaction mixture is treated by the method of Example 3, and 1.63 g of 17og, -benzoyloxy-9y5-chloro-11 / L-hydroxy-21-valeryloxy-1, 4-pregnadien-3, 20-dione are obtained, m.p. 208 ° C.
    Example 1, 2.3 g of 17cc-benzoyloxy-9 (X-chloro-11/5, 21-DIHYDROXY-1.40-pregnadiene-3,20-dione is mixed with 50 ml of pyridine and 25 ml of trimethylacetic anhydride and for 16 h by stirring, they are heated at room temperature. The reaction mixture is processed according to me-5 of the procedure of example 3, and 1.72 g of 17-benzoyloxy-9o-chloro-11/5-hydroxy-21-trimethylacetoxy-1, 4-pregnadien-3, 20- Dione, mp. 236 ° Co
    Example 8. 2.3 g of 17l-benzoyl oxy-9l-chloro-11 / E, 21-DIHYDROXY-1, .4-pregnanedien-3, 20-dione are mixed with 60 ml of pyridine and 25 ml of isobutyl anhydride and stirred at room temperature temperature for 5 to 16 hours. The reaction mixture is treated by the method of make-up artist 4 and 2.1 g of 17-benzoyloxy-9c-chloro-11r hydroxy-21-isobutyryloxy-1, 4 Pregnadieni-3, 20-dione are obtained in the form of a glassy mass, oi + 68- chloroform
    Example 9. 2.3 g of 17ob-benzoyloxy-9og, -chloro-11 b, 21-dihydroxy-1, 4-pregnadiene-3, 20-dione are mixed with 50 ml of pyridine and 20 ml of isov chloride of leleanic acid and mixed in for 2 h at. The reaction mixture was worked up as described in Example 3 and 2.1 g of 17 ° were obtained (- benzoyloxy-9o-chloro-11 (L-hydroxy-21-and zovaleryloxy-1, 4-pregnadiene-3,20-dione, mp. 197 ° C.
    Example 10. 2.3 g of 17cb - benzoyloxy-9c, chloro-11 / b, 21-dihydroxy-1, 4-pregnadiene-3,20-dione is mixed with 50 ml of pyridine and 30 ml of enanthic anhydride and stirred at room temperature for 16 h
    The reaction mixture is poured into ice water, heated, and the excess enanthic acid removed by steam distillation. It is then extracted with dichloromethane, the organic phase is treated by the procedure of Example 3 and 2.03 g of 17–6-benzoyloxy-9 are obtained (X-chloro-21-heptanoyloxy 11p-hydroxy-1, 4-pregnadiene-3, 20-dione in the form of oily product cl 4-64 ° (chloroform).
    Example 11. 2.3g 17os-benzoyloxy-9o.-Chloro-11 | 5, 21-dihydroxy-1, 4-pregnadien-3,20-dione is stirred with 45 ml of pyridine and 1 ml of benzoyl chloride for 1 hour at room temperature .
    The reaction mixture was worked-up as described in Example 3 and 4.5 g of 17ob, 21-dibenzoyloxy-9ob-chloro-11p) -hydroxy-1, 4-pregnadieni-3, 20-dione, ToPl, were obtained.
    Example 12. 7.5 g 9os-chloro-11 (5, 21-trihydroxy-1,4-pregnadien-3, 20-dione is stirred with 45 ml of pyridine and 1 ml of benzoyl chloride for 1 hour at room temperature.
    The reaction mixture was worked-up as described in Example 3 and 4.5 g of 17cb, 21-dibenzoyloxy-9o-chloro-11p-hydroxy-1, 4-pregnadnen-3, 20-dione were obtained, m.p. 22lc.
    Example 13. A. 7.5 g of 9ct-chloro-11 (b, 21-trihydroxy-1,4-pregnadier-3, 20-dione is treated with orthoacetic acid triethyl ester according to the method of example 1. Thus, 17ob, 21- ( 1-ethoxyethylidene dioxy) -9oC, -chloro-11/3-hydroxy-1, 4-pregnadien-3,20-dione as an oily crude product.
    B. The resulting crude product is oropated according to the procedure of Example 1B and thus 5.2 g of 17 cC-acetoxy-9o (, chlorine-11 | b, 21-dihydroxy-1, 4-pregnadien-3, 20-dione, t. Are obtained. mp 205 ° C (decomposition).
    Example 14. 1.0 g of 17os-acetoxy-9ob-chloro-Ills, 21-DIGIDROXI-1, 4-pregnadien-3, 20-dione is mixed with 20 ml of pyridine and 5 ml of acetic anhydride and stirred for 1 h at room temperature The reaction mixture is then poured into ice water, the separated product is filtered off with suction, dissolved in dichloromethane, the organic phase is washed and condensed under vacuum. The residue is recrystallized from acetone hexane and 860 ml of 17ob21-diacetoxy-9o, -chloro-11 -hydroxy-1, 4-pregnadien-3, 20-dione are obtained, m.p. 222 ° C (decomposition).
    Example 15. Under the conditions of Example 4, 1.0 g of 17cC-acetoxy-9ob-chloro-11 b, 21-dihydroxy-1, 4-pregnadien-3, 20-dione is treated with propionic anhydride to give 940 mg of 17 ° ( , -acetoxy-9l-chloro-11r-hydroxy-21-propionyloxy-1, 4-pregnadien-3,20-dione, mp 219 ° C (decomposition).
    Example 16. Under the conditions of Example 6, 1.0 g of 17a, -acetoxy-9l-chloro-llfb, 21-dihydroxy-1, 4-pregnadiene-3,20-dione is treated with valeric anhydride, to give 660 mg of 17 °, -acetoxy-9cX-chloro-11 -hydroxy-21-valeryloxy-1, 4-pregnadien-3, 20-dione, so pl. (decomposition ) .
    Example 17. A- Under the conditions of Example 1A, 7 g of 9o-chloro-11 (b, 17oi, 21-trihydroxy-1, 4-pregnadien-3, 20-dione is treated with triethyl ether of orthopropionic acid, after which 17ob is obtained, 21- (1-ethoxypropyl 1 dinedioxy) -9c3 (, - chloro-11 / L-hydroxy-1, 4-pregnadien-3, 20-dione as a crude product.
    B. The crude crude product obtained is treated under the conditions of Example 1B, after which 2.9 g of 9cy-chloro-11 b, 21-dihydroxy-17ob-propionyloxy-1, 4-pregnadien-3, 20-dione, m.p. . (decomposition).
    Example 18. Under the conditions described in Example 2, 1, 2 g of 9-chloro-11p-21-dihydroxy-17ob-propionyloxy-1, 4-pregnadien-3, 20-dione is treated with formic acid, after which 400 mg are obtained oily 9-bichloro-21-formyloxy-11p) hydroxy-17o-propionyloxy-1, 4-pregnadien-3,20-dione, | x1 + 67 (chloroform).
    Example 19. 700 ml of 9 | X-chloro-11 (2, 21-dihydroxy-17cb-propionyloxy-1, 4-pregnadien-3, 20-dione according to the method of example 3 are treated with acetic anhydride, after which 320 ml of 21- acetoxy-9o (.-chloro-11 (1-hydroxy-1706-PROPIONYLOXY-1, 4-pregnadi-EN-3, 20-dione, mp. 210 C.
    Example 20. 700 ml of 9os-chloro-II (i, 21-dihydroxy-17c-propionyloxy-1, 4-pregnadien-3, 20-dione according to the method of example 4 is treated with propionic anhydride, after which 420 mg of 9os-chloro- 11 / E-hydroxy-17 (Y ,, 21-dipropionyloxy-1, 4-pregnadi. Ane-3,20-dione, so pl. 215s (decomposition).
    Example 21. 650 mg of 9l.-chloro-11p, 21-dihydroxy-17 ° C-propionyloxy-1, 4-pregnadien-3, 20-dione under the conditions of example 5 are treated with butyric anhydride, after which 360 mg of 21-butyryloxy is obtained -9ob- chlorine-lift-hydroxy Ci-17s-propionyl oxy-1, 4-pregnadien-3, 20-dione, m.p. (decomposition).
    Example 22. Under the conditions of Example 6, 700 mg of 9 (X-chloro-11 (3,21-dihydroxy-17oi-propionyl-1, 4-pregnadiene-3, 20-dione is treated with valeric anhydride, then 520 mg are obtained (X-chloro-11/5-hydroxy-17o-propionyloxy-21-valeryloxy-1, 4-pregnadien-3, 20-dione, mp 210 ° C (decomposition).
    Example 23. 3.0 g of 9c6-chloro-llfb, 21-dihydroxy-17l-propionyloxy-1, 4-pregnadien-3, 20-dione is mixed with 30 ml of pyridine and 15 ml of caproic anhydride, stirred for 90 minutes at room temperature. The reaction mixture was worked up as described in Example 3, after which 2.6 g of 9-chloro-21-hexanoyl-11 | 5-hydroxy-17 ° C-propionyloxy-1, 4-pregnadiene-3, 20-dione were obtained.
    EXAMPLE 24 Under the conditions of Example 10, 2.1 g of 9o-chloro-11p, 21-dihydroxy-17ob-propionyloxy-1, 4-pregnadien-3, 20-dione are treated with enanthic anhydride, resulting in 1.02 g of 9 (.- chloro-21-heptanoyloxy-11p-hydroxy-17os-propionyloxy-1, 4-pregnadien-3, 20-dione are obtained.
    Example 25. Under the conditions of Example 7, 1.4 g of 9cC-chloro-11 | 5,21-dihydroxy-17ob-propionyloxy-1, 4-pregnadien-3, 20-dione is treated with trimethylacetic anhydride, 670 mg of 9et-chloro are obtained. lip-hydroxy-17a; -propionyloxy-21-trimethylacetoxy-1, 4-pregnadien-3, 20-dione.
    Example 26. A. Under the conditions of Example 20 25 g 11), 17 ", 21-trihydroxy-1, 4-pregnadien-3, 20-dione is treated with butyric anhydride, after which 23.1 g of 21-butyryloxy are obtained -1 IP, 17ob-dihydroxy-1, 4-pregnadien-3, 20-dione.
    B. To a suspension of 24 g of copper (1) chloride in 480 ml of absolute tetrahydrofuran in an argon atmosphere, 100 ml of a 5% solution of methyl lithium in ether are added dropwise. Then the mixture is cooled to minus and treated with a solution of 22.3 g of 21-butyryloxy-11/2), 17os-dihydroxy-1,4-pregnadiene-3, 20-dione. The mixture is stirred for 4 hours until the initially formed I / L-hydroxy-17 (it, 21- (1-hydroxybutylidenedioxy) 1, 4-pregnadien-3, 20-dione) is rearranged. an aqueous solution of ammonium chloride, extraction with methylene chloride, the organic phase is washed and concentrated under vacuum to obtain 20.3 g of 17Qi-6ytyryloxy-llfb, 21-DIGIDROXI-1,4-pregnadien-3, 20-dione as a crude product.
     B. Under the conditions of Example 3, 20 g of the resulting crude product is treated with acetic anhydride, followed by 14.2 g of 21-acetoxy-17o-butyryloxy-11p-hydroxy-1, 4-pregna0-diene-3,20-dione.
    D. 5.4 g of methanesulfonic acid chloride is added dropwise to a solution of 10 g of 21-acetoxy-17 (x.-butyryloxy-11p-hydroxy-1, 4-pregnadien-3, 205-dione in 50 ml of dimethylformamide and 11 ml of pyridine at room temperature. The reaction mixture is stirred for 2 hours at, then after cooling, it is poured into ice water, treated as indicated in example 3, and 6.5 g of 21-acetoxy-17y-butyryloxy-1, 4 are obtained -9 (11) -pregnatriene-3, 20-dione as a crude product.
    5 D. 6 g of the crude product thus obtained are suspended in 80 ml of dioxane and treated with 5.6 g of N-chlorosuccinimide. 42 ml are then added dropwise over a period of 10 minutes at 20 ° C.
     A 10% aqueous solution of perchlorate acid in the mixture, stirred for 3 hours at 20 ° C, and poured into a solution of 2.5 g of sodium hydrosulfite in 40 ml of water. The precipitated product is precipitated as
     described in example 3, treated and receive 3.1 g of 21-acetoxy-17l-butyryloxy-9sb-chlor-11 | g-hydroxy-1, 4-pregnadien-3, 20-dione, so pl. 215C.
    Example 27 10 ml of hexamethylphosphoric triamide are treated with 1.3 ml of thionyl chloride and stirred for 30 minutes. Then, 800 ml of 17ob5-acetoxy-9os-chlor-lip, 21-dihydroxy is added to the mixture. -1,4-pregnadien-3, 20-dione and continue stirring for 5.5 hours at 0 ° C.
    The mixture is treated as described in Example 3, and 540 mg of 17-acetoxy-9 th, 21-dichloro-11 | 5-hydroxy-1, 4-pregnadien-3, 20-dione are obtained, m.p. 222 ° C (decomposition).
    权利要求:
    Claims (1)
    [1]
    Example 28. Under the conditions of Example 26, 1.2 g of 9l-chloro-11 (3,21-hydroxy-17ob-propionyloxy 1 j 4-pregnadien-3, 20-dione is treated with thionyl chloride and 860 mg are obtained, 21-dichloro- 11 p-hydroxy-17a. Propionyloxy-1,4-pregnadien-3, 20-dione, mp 232 C Example 29, Under the conditions of example 26, 8.5 g of 17 oi-6e Hzoyloxy-9th.-Chloro-11 / are treated B, 21-dihydroxy-1 ,, 4-pregnadien-3, 20-dione and get 4L g 17 (-benzoyloxy-9A, 21-dichloro-11y-hydroxy-1, 4-pregnadiene-35 20-dione, t mp 220 ° C. Example CAS A. 5.0g 9 -chloro -llfb, 17o6j 21-trihydroxy-1, 4-pregnadiene 3, 20 dione is mixed with 500 ml of benzene, 40 ml of dimethylformamide and 500 ml of absolute pyridinosylacetate. The resulting mixture is heated, distilled at a bath temperature of 130 ° C with 50 m solution, 60 ml of triethyl ether o-benzoic acid are added to the distillate and the remaining benzene is distilled again for 2.5 hours. The residue is mixed with 2.4 ml of pyridine, concentrated under vacuum and get 17ot, 21- (l-ethoxybenzylidenedioxy) -9-chloro-11 5-hydroxy-1, 4-pregnadien-3, 20-DION as an oily product, B, the resulting crude product is mixed and mixed with 150 ml of methanol, 54 ml of 0.1 and. aqueous acetic acid and 6 ml of 0.1 But aqueous acetate solution, -;.; ri, and heated for 90 minutes with reverse flow. After that, the reaction mixture is concentrated under vacuum, the residue is mixed with water and extracted with ethyl acetate. The organic phases are washed with water, concentrated under vacuum. The residue is purified on a chrome column with silica gel. SMf is recrystallized from the mixture, .., s; boson with hexane, then the semi-crystallized 3.7 g of 17 °, -benzoyl-oxy 9c 1.-chlorine 11 (5, 21-DIHYDROXY-1,4-pregnadien 3, 20-dione, m.p., 21b ° C (decomposition) Example 31, A, 7.5 g 9l-chlo-11 (5, 21-trihydroxy-1,4-pregnadien-3, 20-dione is treated with triethyl orthoacetic ester according to the procedure of Example 29A. Thus, the 17th., 21- (1-ethoxyethylidene dioxyl) -9o (, chloro-11p-hydroxy -1, -4-pregna d-3, 20-dione in the form of oil crude raw product, B, The resulting crude product is treated in accordance with the procedure of Example 29B. In this way, 5.2 g of 17cb-a1 toxi-9a, -chloro-11 | b, 21-dihydroxy-1, 4-pregnadien-3, 20- are obtained. dione, 205 ° C (decomposition) in Example 32, A, Under the conditions of example 29A, 7 g 9 (-chloro-11p, 17cb, 21.-trihydroxy-1,4-pregnadien-3, 20dione is treated with triethyl ether orthopropionic acid, then 17th., 21- (1-ethoxypropyl-14-dindioxy) is obtained (.-chloro-11 (5-hydroxy Y, 4-pregnadien-3, 20-dione as a crude product. B, The resulting crude crude product is treated under the conditions of Example 29B, after which 2.9 g of 9oi-chloro-ills, 21-dihydroxy-17-propionyloxy-1, 4-pregnadieni-3, 20-dione, t, mp, are obtained 181s (decomposition). Example 33, 1g obtained analogously to example 29A 17oi, 21- (1-ethoxybenzylidene-dioxy) -9os-chloro-11/5-hydroxy-1, 4-pregnadien-3,20-dione is stirred for 2 hours at room temperature with 40 ml dimethylformamide and 4 ml of trimethylsilyl fluoride. After pouring into ice water and the usual treatment, it is evaporated in vacuo. The crude product is purified on silica gel with a mixture of methylene chloride acetone (0-10% acetone). Obtain 240 ml of 17 (H.-Benzoyl-9 ° C-chloro-21-fluoro-11p-hydroxy-1, 4-pregnadiene-3, 20-dione, t, mp, 218C decomposition). Example 34, 5g of crude prepared analogously to example 29A of 960-chloroprednisolone and triethylether. orthoacetic acid 17o., 21- (1-ethoxyethylenedioxy) -9c ": - chloro-11-hydroxy-1, 4-pregnadien-3, 20-dione are treated under nitrogen atmosphere for 1 h with 30 ml of methylene chloride and 3 g of triphenylmethyl chloride, The solvent is distilled off, and the residue is purified 350 g of silica gel with a mixture of methylene chloride and acetone (0-15% acetone. 1.3 g of 17 g. Acetoxy-9ob, 21-dichloro-II-hydroxy-1, 4-pregnadiene-3, are obtained. 20-dione, t, mp, decomposition), oi + 124 ° (pyridine), UV: 239 15200 (methanol). Example 35, 2g crude obtained analogously to example 29A from 9th chloroprednisolone and orthopropionic acid triethyl ester., 21- (1-ethoxypropylidenedioxy) -9l-chloro-11p-hydroxy-1, 4-pregnadien-3, 20-dione is stirred for 2 hours at room temperature with 5 ml of trimethylsilyl chloride in 50 ml of dimethylformamide. After pouring into ice water and conventional treatment, 1.4 g of 9y, 21-dichloro-11p-hydroxy-17ab-propionyloxy-1, 4-pregnadien-3, 20-dione are isolated, which is purified by recrystallization from acetone / hexane, t pl, 232С, +78 (chloroform). UV: 239 15200 (methanol). Formula of isobuthenium. A method of obtaining derivatives of 9-chloroprednisolone of the general formula H0. Lxkr - OK, where R is an alkanoyl group with 1 carbon atoms or a benzoyl group; fluorine atom, chlorine atom, hydroxyl group, characterized in that the ester of the general formula ch. OH 2 C / -. "/ 27: where the alkyl group Cj-C4, the hydrogen atom, the alkyl group Cj-C or the phenyl group, is cleaved hydrolytically or with trimethylsilyl halide or triphenylmethyl halide, after which the resulting target products are separated. Sources of information taken into account examination 1. US patent I 3152154, cl. 260-397.45, published. 1964. Priorities on the grounds: 10/04/766 X is a chlorine atom, 09/21/777 X is a fluorine atom.
    类似技术:
    公开号 | 公开日 | 专利标题
    US5972922A|1999-10-26|Steroids which inhibit angiogenesis
    US3984544A|1976-10-05|Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
    SU751327A3|1980-07-23|Method of preparing 9-chloroprednizolone derivatives
    US4588530A|1986-05-13|Anti-inflammatory prednisolone steroids
    US4176126A|1979-11-27|Novel corticoids
    HU190746B|1986-10-28|Process for producing 6-alpha-methyl-corticoides and pharmaceutical compositions containing them
    EP0056000A2|1982-07-14|17-|methylene steroid derivatives and their preparation
    CA1251784A|1989-03-28|Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them andtheir use as medicaments
    US4232013A|1980-11-04|16,17-Pyrazolino- and 16,17-isopyrazolino-1,4-pregnadiene derivatives
    US4021459A|1977-05-03|Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes
    SU902668A3|1982-01-30|Method of preparing 9-chloroprednisolone derivatives
    IL93477A|1994-07-31|Pregnadiene | dione acetals and ketals, their preparation and pharmaceutical compositions containing them
    EP0149222A2|1985-07-24|6-Alpha, 16 alpha-dimethyl corticoids
    US5776922A|1998-07-07|Corticoid derivatives and pharmaceutical and cosmetic compositions
    US3833563A|1974-09-03|Novel pregnanoic acid derivatives
    US3282929A|1966-11-01|Method for preparation of aromatic a ring steroids
    US4340538A|1982-07-20|Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
    US4185101A|1980-01-22|1,3,5|,6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
    GB1603281A|1981-11-25|Derivatives of 9-fluoroprednisolone
    US3798217A|1974-03-19|Novel c-16,17 spiro-orthoester steroids and preparation
    DD141523A5|1980-05-07|PROCESS FOR THE PRODUCTION OF CORTICIDES
    US3980680A|1976-09-14|Process for the preparation of 21-desoxy-17-acyloxy-4-pregnenes and of 21-iodo-21-desoxy-17-acyl oxy-4-pregnene intermediates useful therein
    FR2474038A1|1981-07-24|17-SPIRO-DIHYDROFURANONES STEROIDAL ANTI-INFLAMMATORY ACTION, AND PROCESS FOR THEIR PREPARATION
    US3396179A|1968-08-06|Process for the preparation of steroidal 6-halomethyl-4, 6-dien-3-ones
    KR820002025B1|1982-10-25|Preparing process for hydro cortison derivatives
    同族专利:
    公开号 | 公开日
    JPS5359654A|1978-05-29|
    CH630098A5|1982-05-28|
    CH632772A5|1982-10-29|
    ATA703577A|1980-01-15|
    IT1113623B|1986-01-20|
    CH631997A5|1982-09-15|
    GR73041B|1984-01-26|
    HU179593B|1982-11-29|
    SE431655B|1984-02-20|
    NO773362L|1978-04-05|
    FR2366313A1|1978-04-28|
    FI58645C|1981-03-10|
    FI772922A|1978-04-05|
    JPS6129960B2|1986-07-10|
    ES462887A1|1978-12-16|
    NL7710869A|1978-04-06|
    NZ185295A|1980-04-28|
    PT67109A|1977-11-01|
    FI58645B|1980-11-28|
    IE45877L|1978-04-04|
    GB1594852A|1981-08-05|
    IL53030D0|1977-11-30|
    PT67109B|1979-03-14|
    SE7711039L|1978-04-05|
    DK438277A|1978-04-05|
    CH632278A5|1982-09-30|
    PL201161A1|1979-01-29|
    IL53030A|1982-11-30|
    PL110392B1|1980-07-31|
    IE45877B1|1982-12-15|
    SU743581A3|1980-06-25|
    NO148597B|1983-08-01|
    AT358202B|1980-08-25|
    NO148597C|1983-11-09|
    LU78223A1|1978-02-01|
    FR2366313B1|1980-02-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    DE1195748B|1961-06-24|1965-07-01|Vismara Francesco Spa|Process for the preparation of 1'-substituted 17alpha, 21- -methylenedioxysteriodes|
    DE2055221A1|1970-11-10|1972-05-18|Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand |17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride|DE2853785A1|1978-12-11|1980-06-19|Schering Ag|NEW PREDNISON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND THE USE THEREOF|
    JPH0374245A|1989-08-12|1991-03-28|Mk Seiko Co Ltd|Car washing machine|
    EP2552449B1|2010-03-26|2017-04-19|Galderma Research & Development|Compositionscomprising brimonidine for the treatment of erythema|
    EP2768502A2|2011-10-19|2014-08-27|Galderma S.A.|Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors|
    CN106632561A|2016-12-16|2017-05-10|广州仁恒医药科技股份有限公司|Method for preparing difluprednate|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE2645105A|DE2645105C2|1976-10-04|1976-10-04|Derivatives of 9-chlorprednisolone, process for their preparation and pharmaceutical preparation containing them|
    DE19772742982|DE2742982C2|1977-09-21|1977-09-21|9-chlorprednisolone derivatives, process for their production and pharmaceutical preparation containing them|
    [返回顶部]